Lesage Anne
SEC CIK 1973705 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PHVS | Pharvaris N.V. | Chief Early Development | 74.0K | — | $6.67M | 15 | 2026-04-22 | 2026-09-17 |
Most active insiders at PHVS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schikan Johannes Gerardus Christiaan Petrus | Dir | — | $9.65M |
| 2 | Lu Peng | Pres | — | $6.95M |
| 3 | Lesage Anne | Chief Early Development | — | $6.67M |
| 4 | Bjork Elisabeth | Dir | — | $2.28M |
| 5 | Abele Stefan Andreas | Chief Technical Ops Off | — | $2.03M |
| 6 | Glassman Robert | Dir | — | $1.49M |
| 7 | Souverijns Wim | Chief Commercial Off | — | $1.32M |
| 8 | Modig Berndt | CEO, Dir | — | $1.10M |
| 9 | Nassif David W. | CFO, CLO | — | $521.9K |
| 10 | Nijdam Anna | Principal Accounting Off | — | $307.5K |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-09-21 15:13 | 2026-09-17 | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale | $38.27 | -20.0K | 74.0K | -21% | -$765.5K |
| DT | 2026-09-14 12:29 | 2026-09-10 | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | M - OptEx | $8.05 | +30.0K | 86.5K | +53% | +$241.5K |
| DT | 2026-09-14 12:29 | 2026-09-10 | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale+OE | $38.30 | -30.0K | 56.5K | -35% | -$1.15M |
| DMT | 2026-07-01 19:02 | 2026-06-29+ | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | M - OptEx | $6.85 | +38.5K | 86.6K | +80% | +$263.4K |
| DMT | 2026-07-01 19:02 | 2026-06-29+ | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale+OE | $35.37 | -38.5K | 58.8K | -40% | -$1.36M |
| DMTI | 2026-07-01 19:02 | 2026-06-29+ | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale+OE | $35.41 | -37.7K | 94.0K | -29% | -$1.33M |
| DMT | 2026-06-29 18:41 | 2026-06-25 | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | M - OptEx | $4.73 | +2,300 | 58.8K | +4% | +$10.9K |
| DT | 2026-06-29 18:41 | 2026-06-25 | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale+OE | $35.12 | -2,300 | 56.5K | -4% | -$80.8K |
| DTI | 2026-06-29 18:41 | 2026-06-25 | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale+OE | $35.12 | -2,300 | 131.7K | -2% | -$80.8K |
| DMT | 2026-05-01 19:30 | 2026-04-29+ | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | M - OptEx | $6.46 | +25.4K | 74.5K | +52% | +$164.1K |
| DMT | 2026-05-01 19:30 | 2026-04-29+ | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale+OE | $30.23 | -25.4K | 56.5K | -31% | -$767.8K |
| DMTI | 2026-05-01 19:30 | 2026-04-29+ | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale+OE | $30.22 | -22.9K | 134.0K | -15% | -$692.1K |
| DMT | 2026-04-24 12:18 | 2026-04-22+ | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | M - OptEx | $7.62 | +7,600 | 56.5K | +16% | +$57.9K |
| DMT | 2026-04-24 12:18 | 2026-04-22+ | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale+OE | $30.05 | -7,600 | 56.5K | -12% | -$228.4K |
| DMTI | 2026-04-24 12:18 | 2026-04-22+ | PHVS | Pharvaris N.V. | Lesage Anne | Chief Early Development | S - Sale+OE | $30.05 | -7,100 | 156.9K | -4% | -$213.4K |
Purchase Sale Sale after option exercise All abbreviations